Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bassem Shebl

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods in Enzymology|November 30, 2014
Ribosome structure and dynamics by smFRET microscopyBassem Shebl, Zenia Norman, Peter V Cornish
Archives of Biochemistry and Biophysics|May 22, 2016
Preparation of ribosomes for smFRET studies: A simplified approachBassem Shebl, Drew E Menke, Min Pennella, et al.
RNA (New York, N.Y.)|April 17, 2025
The influence of downstream structured elements within mRNA on the dynamics of intersubunit rotation in ribosomesBassem Shebl, Anna Pavlova, Preston Kellenberger, et al.
ACS Chemical Biology|August 13, 2024
Targeted Degradation of Protein Kinase A via a Stapled Peptide PROTACMatthew K Whittaker, George N Bendzunas, Mahsa Shirani, et al.
Stem Cell Reports|July 8, 2022
Human liver organoids for disease modeling of fibrolamellar carcinomaNicole J C Narayan, David Requena, Gadi Lalazar, et al.
Science Advances|June 21, 2023
Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinomaSolomon N Levin, Michael D Tomasini, James Knox, et al.
Cancer Research|June 18, 2024
Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1Mahsa Shirani, Solomon Levin, Bassem Shebl, et al.
JCI Insight|September 8, 2022
Targeting BCL-XL in fibrolamellar hepatocellular carcinomaBassem Shebl, Denise Ng, Gadi Lalazar, et al.
Cancer Discovery|June 15, 2021
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient ScreeningGadi Lalazar, David Requena, Lavoisier Ramos-Espiritu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods in Enzymology|November 30, 2014
Ribosome structure and dynamics by smFRET microscopyBassem Shebl, Zenia Norman, Peter V Cornish
Archives of Biochemistry and Biophysics|May 22, 2016
Preparation of ribosomes for smFRET studies: A simplified approachBassem Shebl, Drew E Menke, Min Pennella, et al.
RNA (New York, N.Y.)|April 17, 2025
The influence of downstream structured elements within mRNA on the dynamics of intersubunit rotation in ribosomesBassem Shebl, Anna Pavlova, Preston Kellenberger, et al.
ACS Chemical Biology|August 13, 2024
Targeted Degradation of Protein Kinase A via a Stapled Peptide PROTACMatthew K Whittaker, George N Bendzunas, Mahsa Shirani, et al.
Stem Cell Reports|July 8, 2022
Human liver organoids for disease modeling of fibrolamellar carcinomaNicole J C Narayan, David Requena, Gadi Lalazar, et al.
Science Advances|June 21, 2023
Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinomaSolomon N Levin, Michael D Tomasini, James Knox, et al.
Cancer Research|June 18, 2024
Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1Mahsa Shirani, Solomon Levin, Bassem Shebl, et al.
JCI Insight|September 8, 2022
Targeting BCL-XL in fibrolamellar hepatocellular carcinomaBassem Shebl, Denise Ng, Gadi Lalazar, et al.
Cancer Discovery|June 15, 2021
Identification of Novel Therapeutic Targets for Fibrolamellar Carcinoma Using Patient-Derived Xenografts and Direct-from-Patient ScreeningGadi Lalazar, David Requena, Lavoisier Ramos-Espiritu, et al.
Pageof 1